Comparison of OS
| Report . | Stanford . | MDA-1* . | MDA-2 . | French . | EMBT . | CIBMTR . |
|---|---|---|---|---|---|---|
| No. of patients | 35 | 19 | 47 | 37 | 60 | 129 |
| Age, median (range), y | 62 (20-74) | 50 (21-63) | 51.5 (19-72) | 44 (9-63) | 46.5 (22-66) | 47 (22-72) |
| OS, % | ||||||
| 1-y | 80 | NA | NA | 65 | 66 | 54 |
| 2-y | 68 | 79 | NA | 57 | NA | NA |
| 3-y | 62 | NA | NA | NA | 53 | 38 |
| 4-y | 59 | NA | 51 | NA | NA | NA |
| 5-y | 56 | NA | NA | NA | 46 | 32 |
| Report . | Stanford . | MDA-1* . | MDA-2 . | French . | EMBT . | CIBMTR . |
|---|---|---|---|---|---|---|
| No. of patients | 35 | 19 | 47 | 37 | 60 | 129 |
| Age, median (range), y | 62 (20-74) | 50 (21-63) | 51.5 (19-72) | 44 (9-63) | 46.5 (22-66) | 47 (22-72) |
| OS, % | ||||||
| 1-y | 80 | NA | NA | 65 | 66 | 54 |
| 2-y | 68 | 79 | NA | 57 | NA | NA |
| 3-y | 62 | NA | NA | NA | 53 | 38 |
| 4-y | 59 | NA | 51 | NA | NA | NA |
| 5-y | 56 | NA | NA | NA | 46 | 32 |
CIBMTR, Center for the International Blood and Marrow Transplant (2014 report)23 ; EBMT, European Group for Blood and Marrow Transplantation (2010 report)21 ; French, Masson et al(2014 report)19; MDA-1, MD Anderson Cancer Center (2010 report)18 ; MDA-2, MD Anderson Cancer Center (2015 report),22 NA, not available.
*Data were also included in MDA-2 report.